FLRAX
Price
$40.29
Change
+$0.40 (+1.00%)
Updated
Jun 6 closing price
Net Assets
43.8M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

FLRAX vs VITSX

Header iconFLRAX vs VITSX Comparison
Open Charts FLRAX vs VITSXBanner chart's image
Nuveen Large Cap Select A
Price$40.29
Change+$0.40 (+1.00%)
VolumeN/A
Net Assets43.8M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
FLRAX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FLRAX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLRAX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. FLRAX (43.8M). VITSX pays higher dividends than FLRAX: VITSX (1.29) vs FLRAX (0.25). FLRAX was incepted earlier than VITSX: FLRAX (22 years) vs VITSX (28 years). FLRAX (1.27) is less costly to investors than VITSX (0.03). FLRAX is a more actively managed with annual turnover of: 76.00 vs. VITSX (2.00). FLRAX has a lower initial minimum investment than VITSX: FLRAX (3000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. FLRAX (-4.33). VITSX return over 5 years is better than : 80.96 vs. FLRAX (29.23).
FLRAXVITSXFLRAX / VITSX
Total Expense Ratio1.010.033,367%
Annual Report Gross Expense Ratio1.270.034,233%
Fund Existence22 years28 years-
Gain YTD-0.8940.833-107%
Front Load6%N/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets43.8M1.82T0%
Annual Yield % from dividends0.251.2919%
Returns for 1 year-4.3310.97-40%
Returns for 3 years22.2640.3555%
Returns for 5 years29.2380.9636%
Returns for 10 years95.03180.4953%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.